No delayed restenosis at 18 months after implantation of sirolimus-eluting stent.
Sirolimus-eluting stent is emerging as a potential solution for the prevention of restenosis. Recently, a sustained suppression of neointimal proliferation 12 months after implantation of this stent was reported. This is the first report of angiographic and IVUS images 18 months after the implantation of a sirolimus-eluting stent.
Tanabe
Kengo
K
Department of Cardiology, Thoraxcenter, University Hospital Rotterdam, Rotterdam, The Netherlands.
Degertekin
Muzaffer
M
Regar
Evelyn
E
Ligthart
Jurgen M R
JM
van der Giessen
Willem J
WJ
Serruys
Patrick W
PW
D000328:Adult; D019917:Blood Vessel Prosthesis Implantation; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000188:drug therapy* / Q000209:etiology*; D020878:Device Removal; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D013997:Time Factors; D018084:Ultrasonography, Interventional
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D020123:Sirolimus